214 related articles for article (PubMed ID: 29752404)
1. Low-density lipoprotein receptor-related protein-1 dysfunction synergizes with dietary cholesterol to accelerate steatohepatitis progression.
Hamlin AN; Chinnarasu S; Ding Y; Xian X; Herz J; Jaeschke A; Hui DY
J Biol Chem; 2018 Jun; 293(25):9674-9684. PubMed ID: 29752404
[TBL] [Abstract][Full Text] [Related]
2. LRP1 Protein Deficiency Exacerbates Palmitate-induced Steatosis and Toxicity in Hepatocytes.
Hamlin AN; Basford JE; Jaeschke A; Hui DY
J Biol Chem; 2016 Aug; 291(32):16610-9. PubMed ID: 27317662
[TBL] [Abstract][Full Text] [Related]
3. Hepatic deficiency of low density lipoprotein receptor-related protein-1 reduces high density lipoprotein secretion and plasma levels in mice.
Basford JE; Wancata L; Hofmann SM; Silva RA; Davidson WS; Howles PN; Hui DY
J Biol Chem; 2011 Apr; 286(15):13079-87. PubMed ID: 21343303
[TBL] [Abstract][Full Text] [Related]
4. Hepatic LDL receptor-related protein-1 deficiency alters mitochondrial dynamics through phosphatidylinositol 4,5-bisphosphate reduction.
Chinnarasu S; Alogaili F; Bove KE; Jaeschke A; Hui DY
J Biol Chem; 2021; 296():100370. PubMed ID: 33548224
[TBL] [Abstract][Full Text] [Related]
5. Vertical Sleeve Gastrectomy Attenuates the Progression of Non-Alcoholic Steatohepatitis in Mice on a High-Fat High-Cholesterol Diet.
Whang E; Liu Y; Kageyama S; Woo SL; Yang J; Lee R; Li Z; Ji H; Chen Y; Kupiec-Weglinski JW
Obes Surg; 2019 Aug; 29(8):2420-2429. PubMed ID: 30982168
[TBL] [Abstract][Full Text] [Related]
6. Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice.
Foley EM; Gordts PLSM; Stanford KI; Gonzales JC; Lawrence R; Stoddard N; Esko JD
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2065-74. PubMed ID: 23846497
[TBL] [Abstract][Full Text] [Related]
7. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
8. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.
Subramanian S; Goodspeed L; Wang S; Kim J; Zeng L; Ioannou GN; Haigh WG; Yeh MM; Kowdley KV; O'Brien KD; Pennathur S; Chait A
J Lipid Res; 2011 Sep; 52(9):1626-35. PubMed ID: 21690266
[TBL] [Abstract][Full Text] [Related]
9. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
10. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
11. Mutation in the distal NPxY motif of LRP1 alleviates dietary cholesterol-induced dyslipidemia and tissue inflammation.
Jaeschke A; Haller A; Cash JG; Nam C; Igel E; Roebroek AJM; Hui DY
J Lipid Res; 2021; 62():100012. PubMed ID: 33500241
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
13. The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins.
Fischer AW; Albers K; Krott LM; Hoffzimmer B; Heine M; Schmale H; Scheja L; Gordts PLSM; Heeren J
Mol Metab; 2018 Oct; 16():88-99. PubMed ID: 30100244
[TBL] [Abstract][Full Text] [Related]
14. Low-Density Lipoprotein Receptor-Related Protein-1 Protects Against Hepatic Insulin Resistance and Hepatic Steatosis.
Ding Y; Xian X; Holland WL; Tsai S; Herz J
EBioMedicine; 2016 May; 7():135-45. PubMed ID: 27322467
[TBL] [Abstract][Full Text] [Related]
15. Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis.
Van Rooyen DM; Larter CZ; Haigh WG; Yeh MM; Ioannou G; Kuver R; Lee SP; Teoh NC; Farrell GC
Gastroenterology; 2011 Oct; 141(4):1393-403, 1403.e1-5. PubMed ID: 21703998
[TBL] [Abstract][Full Text] [Related]
16. A Diterpenoid, 14-Deoxy-11, 12-Didehydroandrographolide, in
Liu YT; Chen HW; Lii CK; Jhuang JH; Huang CS; Li ML; Yao HT
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32085637
[TBL] [Abstract][Full Text] [Related]
17. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet.
Kamada Y; Kiso S; Yoshida Y; Chatani N; Kizu T; Hamano M; Tsubakio M; Takemura T; Ezaki H; Hayashi N; Takehara T
Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G1031-43. PubMed ID: 21885686
[TBL] [Abstract][Full Text] [Related]
18. Cholic acid supplementation accelerates the progression of nonalcoholic fatty liver disease to the procarcinogenic state in mice fed a high-fat and high-cholesterol diet.
Chun HJ; Shim YJ; Kwon YH
J Nutr Biochem; 2022 Feb; 100():108869. PubMed ID: 34563665
[TBL] [Abstract][Full Text] [Related]
19. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
Jeong MJ; Kim SR; Jung UJ
Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol Induces Nrf-2- and HIF-1
Kaminsky-Kolesnikov Y; Rauchbach E; Abu-Halaka D; Hahn M; García-Ruiz C; Fernandez-Checa JC; Madar Z; Tirosh O
Oxid Med Cell Longev; 2020; 2020():5393761. PubMed ID: 32566088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
